Fareed Zakaria: ‘Biden should learn something from Trump’ on the border

Author and journalist Fareed Zakaria joins Margaret Hoover to talk about his recent book, “Age of Revolutions,” and how past periods of progress and backlash inform our present revolutionary moment.

Zakaria, host of CNN’s “Fareed Zakaria GPS,” reflects on a full-blown cultural backlash against decades of social and political change that has fueled the rise of Donald Trump. He also discusses the next industrial revolution driven by artificial intelligence and the progress and disruption it may cause.

Zakaria comments on the challenge President Biden faces addressing the crisis at the southern border. He also addresses campus protests over Israel’s actions in Gaza and what he sees as the failure of Biden’s efforts to influence Israeli policy.

Assessing America’s place in a changing world, Zakaria makes an argument for aggressive U.S. support for Ukraine and voices concern about the impact of emerging Republican isolationism in a second Trump presidency. He discusses the race between Trump and Biden, the prospect of a historic political realignment, and the parallels between 1968 and 2024.

(NOTE: This interview was recorded on May 1, prior to the announcement that the U.S. has put arms shipments to Israel on hold out of concern that American weapons would be used in an assault on the city of Rafah.)

Support for “Firing Line for Margaret Hoover” is provided by Robert Granieri, Vanessa and Henry Cornell, The Fairweather Foundation, The Tepper Foundation, Peter and Mary Kalikow, The Asness Family Foundation, The Beth and Ravenel Curry Foundation, Kathleen and Andrew McKenna through The McKenna Family Foundation, Charles R. Schwab, The Eric and Wendy Schmidt Fund for Strategic Innovation, Pritzker Military Foundation on behalf of the Pritzker Military Museum and Library, The Rosalind P. Walter Foundation, Damon Button, Craig Newmark Philanthropies, The Marc Haas Foundation, Roger and Susan Hertog, Cheryl Cohen Effron and Blair Effron, and Al and Kathy Hubbard. Corporate funding is provided by Stephens Inc. and Pfizer Inc.